CIK 0001833214 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SAB Biotherapeutics, Inc.
Sign in to watch- Ticker
- SABS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 853899721
- Phone
- 305-845-2813
- Business address
- 777 W 41ST ST, SUITE 401, MIAMI BEACH, FL, 33140
- Former names
- Big Cypress Acquisition Corp.
- 8-K Event Executive or director change · Regulation FD disclosure
- S-3/A Offering Registration Statement
- 4/A Insider Changes in Ownership
- 4/A Insider Changes in Ownership
- 4 Insider Changes in Ownership
- DEFA14A Proxy Proxy Materials
- 8-K/A Event Unregistered share sale · Other events
- 4 Insider Changes in Ownership
- 10-Q Report Quarterly Report
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- 4 Insider Changes in Ownership
- 3 Insider Initial Statement of Ownership
- DEF 14A Proxy Proxy Statement
- 8-K Event Material agreement · Executive or director change
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- PRE 14A Proxy Proxy Statement (Preliminary)
- D Other Notice of Sales of Unregistered Securities
- SC 13G Stake Amended Statement of Ownership
Page 9 of 22 · 433 filings